Related Experiment Video
Updated: Jun 28, 2026
07:20
Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
[Multidisciplinary therapy for focal spasticity treatment].
1Neurologische Rehabilitationsklinik Beelitz-Heilstätten, Kliniken Beelitz GmbH, Beelitz-Heilstätten. wissel@rehaklinik-beelitz.de
Der Nervenarzt
|October 18, 2008
Summary
Botulinum toxin type A (BTA) injections effectively treat focal dystonias and spasticity. Combining BTA with guided injections and therapies like casting enhances functional outcomes and quality of life.
Area of Science:
- Neurology
- Pharmacology
Context:
- Focal dystonias and spastic syndromes are debilitating neurological conditions.
- Local intramuscular injections of botulinum toxin type A (BTA) are a primary treatment.
- Current BTA therapy aims to reduce movement disorders, pain, and improve quality of life.
Purpose:
- To explore methods for enhancing the efficacy and functional outcomes of BTA injections.
- To identify adjunctive therapies that complement BTA treatment for spasticity.
Summary:
- BTA injections are the preferred treatment for focal dystonias and spasticity.
- Electrical or sonographical guidance improves BTA injection accuracy and functional outcomes.
- Enhancing BTA efficacy involves targeting active synapses and employing methods like casting, splinting, and electrical stimulation for muscle activation and length restoration.
Impact:
- Optimizing BTA treatment through guided injections and complementary therapies can significantly improve patient function and quality of life.
- Multidisciplinary approaches, including patient and family involvement, are crucial for maximizing therapeutic benefits in managing disabling spasticity.
